isoproterenol has been researched along with tamoxifen in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Kirk, K; Powell, T; Vandenberg, JI; Yoshida, A | 1 |
| Bian, JS; Kwan, YW; Li, HY; Wong, TM | 1 |
| Greenberg, AS; Kraemer, FB; Muliro, K; Patel, S; Roth, RA; Shen, WJ; Souza, SC | 1 |
| He, J; Jin, X; Yin, N; Yin, Z | 1 |
| Desai, VJ; Patel, BM | 1 |
| Patel, BM; Rayabarapu, N | 1 |
| Bruzzone, A; Copsel, S; Davio, C; Gargiulo, L; Lamb, C; Lanari, C; Lüthy, IA; Lydon, J; May, M; Rivero, EM | 1 |
| Calimli, MH; Kanberoğlu, GS; Karaman, M; Türkan, F | 1 |
1 review(s) available for isoproterenol and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for isoproterenol and tamoxifen
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Swelling-activated and isoprenaline-activated chloride currents in guinea pig cardiac myocytes have distinct electrophysiology and pharmacology.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anthracenes; Cell Size; Chloride Channels; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Iodine; Isoproterenol; Membrane Potentials; Myocardium; Osmolar Concentration; Patch-Clamp Techniques; Tamoxifen | 1994 |
Enhanced responses to 17beta-estradiol in rat hearts treated with isoproterenol: involvement of a cyclic AMP-dependent pathway.
Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channels; Cell Membrane; Cyclic AMP; Estradiol; Estrogen Antagonists; Female; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Reperfusion Injury; Myocardium; Ovariectomy; Perfusion; Rats; Rats, Sprague-Dawley; Signal Transduction; Tamoxifen | 2000 |
Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway.
Topics: 3T3 Cells; Animals; Binding Sites; Cell Differentiation; CHO Cells; Cricetinae; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Immunoblotting; Isoproterenol; Lipolysis; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Phosphorylation; Plasmids; Serine; Signal Transduction; Sterol Esterase; Tamoxifen; Time Factors; Transfection | 2001 |
Effects of adrenergic agents on the expression of zebrafish (Danio rerio) vitellogenin Ao1.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Isoproterenol; Liver; Moxisylyte; Myocardium; Phenylephrine; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Vitellogenins; Zebrafish | 2009 |
Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy.
Topics: Animals; Blood Pressure; C-Reactive Protein; Cardiomegaly; Disease Models, Animal; Female; Heart Rate; Isoproterenol; L-Lactate Dehydrogenase; Lipoproteins, LDL; Myocytes, Cardiac; Oxidative Stress; Protein Kinase C; Rats; Rats, Wistar; Tamoxifen | 2014 |
Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Collagen; Female; Heart Ventricles; Hemodynamics; Isoproterenol; Lipid Metabolism; Myocardial Infarction; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Sodium-Potassium-Exchanging ATPase; Tamoxifen | 2014 |
A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
Topics: Animals; Breast Neoplasms; Catecholamines; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Estradiol; Estrogens; Female; Fulvestrant; Humans; Isoproterenol; Mammary Glands, Animal; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morphogenesis; Receptors, Adrenergic, beta-2; Receptors, Estrogen; Tamoxifen | 2017 |
Inhibition effects of isoproterenol, chlorpromazine, carbamazepine, tamoxifen drugs on glutathione S-transferase, cholinesterases enzymes and molecular docking studies.
Topics: Acetylcholinesterase; Carbamazepine; Chlorpromazine; Cholinesterase Inhibitors; Glutathione Transferase; Isoproterenol; Molecular Docking Simulation; Pharmaceutical Preparations; Tamoxifen | 2021 |